NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF

EBioMedicine

Volumn 16, Issue , 2017, Pages 63-75

  Fane, Mitchell E ^a,b   Chhabra, Yash ^a,b   Hollingsworth, David E J ^a   Simmons, Jacinta L ^c   Spoerri, Loredana ^a   Oh, Tae Gyu ^a   Chauhan, Jagat ^d   Chin, Toby ^a   Harris, Lachlan ^a   Harvey, Tracey J ^a   Muscat, George E O ^a   Goding, Colin R ^d   Sturm, Richard A ^a   Haass, Nikolas K ^a   Boyle, Glen M ^c   Piper, Michael ^a   Smith, Aaron G ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

BRN2; Epigenetic; Invasion; Melanoma; Metastasis; NFIB

Indexed keywords

DOXYCYCLINE; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EZH2; EZH2 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MITF PROTEIN, HUMAN; NFIB PROTEIN, HUMAN; NUCLEAR FACTOR I; PROTEIN BINDING; TRANSCRIPTION FACTOR BRN-2; TRANSCRIPTION FACTOR POU;

ARTICLE; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; IMMUNOFLUORESCENCE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR INVASION; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; MELANOMA; MICE, INBRED BALB C; MICE, KNOCKOUT; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; NFI TRANSCRIPTION FACTORS; POU DOMAIN FACTORS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 85009985653     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2017.01.013     Document Type: Article

References (53)

1. Arozarena, I., Sanchez-Laorden, B., Packer, L., Hidalgo-Carcedo, C., Hayward, R., Viros, A., Sahai, E., Marais, R., Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A. Cancer Cell 19 (2011), 45–57.
2. Bachmann, I.M., Halvorsen, O.J., Collett, K., Stefansson, I.M., Straume, O., Haukaas, S.A., Salvesen, H.B., Otte, A.P., Akslen, L.A., EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J. Clin. Oncol. 24 (2006), 268–273.
3. Beaumont, K.A., Mohana-Kumaran, N., Haass, N.K., Modeling melanoma in vitro and in vivo. Healthcare 2 (2014), 27–46.
4. Beaumont, K.A., Anfosso, A., Ahmed, F., Weninger, W., Haass, N.K., Imaging- and flow cytometry-based analysis of cell position and the cell cycle in 3D melanoma spheroids. J. Vis. Exp., 106, 2015, e53486.
5. Boyle, G.M., Woods, S.L., Bonazzi, V.F., Stark, M.S., Hacker, E., Aoude, L.G., Dutton-Regester, K., Cook, A.L., Sturm, R.A., Hayward, N.K., Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell Melanoma Res. 24 (2011), 525–537.
6. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L., Goding, C.R., Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20 (2006), 3426–3439.
7. Chang, C.Y., Pasolli, H.A., Giannopoulou, E.G., Guasch, G., Gronostajski, R.M., Elemento, O., Fuchs, E., NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche. Nature 495 (2013), 98–102.
8. Chapman, A., Fernandez del Ama, L., Ferguson, J., Kamarashev, J., Wellbrock, C., Hurlstone, A., Heterogeneous tumor subpopulations cooperate to drive invasion. Cell Rep. 8 (2014), 688–695.
9. Cheng, L., Slezak, J., Bergstralh, E.J., Cheville, J.C., Sweat, S., Zincke, H., Bostwick, D.G., Dedifferentiation in the metastatic progression of prostate carcinoma. Cancer 86 (1999), 657–663.
10. Cook, A.L., Sturm, R.A., POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis. Pigment Cell Melanoma Res. 21 (2008), 611–626.
11. Cook, A.L., Donatien, P.D., Smith, A.G., Murphy, M., Jones, M.K., Herlyn, M., Bennett, D.C., Leonard, J.H., Sturm, R.A., Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3. J. Invest. Dermatol. 121 (2003), 1150–1159.
12. Cook, A.L., Smith, A.G., Smit, D.J., Leonard, J.H., Sturm, R.A., Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro. Exp. Cell Res. 308 (2005), 222–235.
13. Denny, S.K., Yang, D., Chuang, C.H., Brady, J.J., Lim, J.S., Gruner, B.M., Chiou, S.H., Schep, A.N., Baral, J., Hamard, C., et al. Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell 166 (2016), 328–342.
14. Dooley, A.L., Winslow, M.M., Chiang, D.Y., Banerji, S., Stransky, N., Dayton, T.L., Snyder, E.L., Senna, S., Whittaker, C.A., Bronson, R.T., et al. Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev. 25 (2011), 1470–1475.
15. Fan, T., Jiang, S.L., Chung, N., Alikhan, A., Ni, C., Lee, C.C.R., Hornyak, T.J., EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol. Cancer Res. 9 (2011), 418–429.
16. Fang, D., Nguyen, T.K., Leishear, K., Finko, R., Kulp, A.N., Hotz, S., Van Belle, P.A., Xu, X., Elder, D.E., Herlyn, M., A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65 (2005), 9328–9337.
17. Friedmann-Morvinski, D., Verma, I.M., Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep. 15 (2014), 244–253.
18. Goding, C.R., Commentary. A picture of Mitf in melanoma immortality. Oncogene 30 (2011), 2304–2306.
19. Goodall, J., Carreira, S., Denat, L., Kobi, D., Davidson, I., Nuciforo, P., Sturm, R.A., Larue, L., Goding, C.R., Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Cancer Res. 68 (2008), 7788–7794.
20. Grunder, A., Ebel, T.T., Mallo, M., Schwarzkopf, G., Shimizu, T., Sippel, A.E., Schrewe, H., Nuclear factor I-B (Nfib) deficient mice have severe lung hypoplasia. Mech. Dev. 112 (2002), 69–77.
21. Haass, N.K., Beaumont, K.A., Hill, D.S., Anfosso, A., Mrass, P., Munoz, M.A., Kinjyo, I., Weninger, W., Real-time cell cycle imaging during melanoma growth, invasion, and drug response. Pigment Cell Melanoma Res. 27 (2014), 764–776.
22. Harris, L., Genovesi, L.A., Gronostajski, R.M., Wainwright, B.J., Piper, M., Nuclear factor one transcription factors: divergent functions in developmental versus adult stem cell populations. Dev. Dyn. 244 (2015), 227–238.
23. Hartman, M.L., Czyz, M., MITF in melanoma: mechanisms behind its expression and activity. Cell. Mol. Life Sci. 72 (2015), 1249–1260.
24. Hoek, K.S., Goding, C.R., Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 23 (2010), 746–759.
25. Hoek, K.S., Eichhoff, O.M., Schlegel, N.C., Doebbeling, U., Kobert, N., Schaerer, L., Hemmi, S., Dummer, R., In vivo switching of human melanoma cells between proliferative and invasive states. Pigment Cell Melanoma Res., 21, 2008, 269.
26. Hsu, Y.C., Osinski, J., Campbell, C.E., Litwack, E.D., Wang, D., Liu, S., Bachurski, C.J., Gronostajski, R.M., Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation. Dev. Biol. 354 (2011), 242–252.
27. Kobi, D., Steunou, A.L., Dembele, D., Legras, S., Larue, L., Nieto, L., Davidson, I., Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene. Pigment Cell Melanoma Res. 23 (2010), 404–418.
28. Levy, C., Khaled, M., Fisher, D.E., MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 12 (2006), 406–414.
29. Luo, C.L., Merz, P.R., Chen, Y.W., Dickes, E., Pscherer, A., Schadendorf, D., Eichmuller, S.B., MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2. Cancer Lett. 341 (2013), 240–247.
30. Manning, C.S., Hooper, S., Sahai, E.A., Intravital imaging of SRF and Notch signalling identifies a key role for EZH2 in invasive melanoma cells. Oncogene 34 (2015), 4320–4332.
31. Marusyk, A., Almendro, V., Polyak, K., Intra-tumour heterogeneity: a looking glass for cancer?. Nat. Rev. Cancer 12 (2012), 323–334.
32. Moon, H.G., Hwang, K.T., Kim, J.A., Kim, H.S., Lee, M.J., Jung, E.M., Ko, E., Han, W., Noh, D.Y., NFIB is a potential target for estrogen receptor-negative breast cancers. Mol. Oncol. 5 (2011), 538–544.
33. Nowell, P.C., The clonal evolution of tumor cell populations. Science 194 (1976), 23–28.
34. Persson, M., Andren, Y., Mark, J., Horlings, H.M., Persson, F., Stenman, G., Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 18740–18744.
35. Pinner, S., Jordan, P., Sharrock, K., Bazley, L., Collinson, L., Marais, R., Bonvin, E., Goding, C., Sahai, E., Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res. 69 (2009), 7969–7977.
36. Piper, M., Barry, G., Harvey, T.J., McLeay, R., Smith, A.G., Harris, L., Mason, S., Stringer, B.W., Day, B.W., Wray, N.R., et al. NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development. J. Neurosci. 34 (2014), 2921–2930.
37. Pjanic, M., Pjanic, P., Schmid, C., Ambrosini, G., Gaussin, A., Plasari, G., Mazza, C., Bucher, P., Mermod, N., Nuclear factor I revealed as family of promoter binding transcription activators. BMC Genomics, 2011, 12.
38. Quintana, E., Shackleton, M., Foster, H.R., Fullen, D.R., Sabel, M.S., Johnson, T.M., Morrison, S.J., Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18 (2010), 510–523.
39. Reya, T., Morrison, S.J., Clarke, M.F., Weissman, I.L., Stem cells, cancer, and cancer stem cells. Nature 414 (2001), 105–111.
40. Santiago-Walker, A., Li, L., Haass, N.K., Herlyn, M., Melanocytes: from morphology to application. Skin Pharmacol. Physiol. 22 (2009), 114–121.
41. Scott, K.L., Nogueira, C., Heffernan, T.P., van Doorn, R., Dhakal, S., Hanna, J.A., Min, C., Jaskelioff, M., Xiao, Y., Wu, C.J., et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell 20 (2011), 92–103.
42. Sell, S., Cellular-origin of cancer — dedifferentiation or stem-cell maturation arrest. Environ. Health Perspect. 101 (1993), 15–26.
43. Semenova, E.A., Kwon, M.C., Monkhorst, K., Song, J.Y., Bhaskaran, R., Krijgsman, O., Kuilman, T., Peters, D., Buikhuisen, W.A., Smit, E.F., et al. Transcription factor NFIB is a driver of small cell lung cancer progression in mice and marks metastatic disease in patients. Cell Rep. 16 (2016), 631–643.
44. Smalley, K.S., Lioni, M., Noma, K., Haass, N.K., Herlyn, M., In vitro three-dimensional tumor microenvironment models for anticancer drug discovery. Expert Opin. Drug Discovery 3 (2008), 1–10.
45. Spoerri, L., Beaumont, K.A., Anfosso, A., Haass, N.K., Real-time cell cycle imaging in a 3D cell culture model of melanoma. Methods Mol. Biol., 2017 (in press).
46. Steele-Perkins, G., Plachez, C., Butz, K.G., Yang, G.H., Bachurski, C.J., Kinsman, S.L., Litwack, E.D., Richards, L.J., Gronostajski, R.M., The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol. Cell. Biol. 25 (2005), 685–698.
47. Thurber, A.E., Douglas, G., Sturm, E.C., Zabierowski, S.E., Smit, D.J., Ramakrishnan, S.N., Hacker, E., Leonard, J.H., Herlyn, M., Sturm, R.A., Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Oncogene 30 (2011), 3036–3048.
48. Vandamme, N., Berx, G., Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity. Front. Oncol., 4, 2014, 352.
49. Verfaillie, A., Imrichova, H., Atak, Z.K., Dewaele, M., Rambow, F., Hulselmans, G., Christiaens, V., Svetlichnyy, D., Luciani, F., Van den Mooter, L., et al. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nat. Commun., 6, 2015.
50. Wellbrock, C., Arozarena, I., Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy. Pigment Cell Melanoma Res. 28 (2015), 390–406.
51. Wellbrock, C., Rana, S., Paterson, H., Pickersgill, H., Brummelkamp, T., Marais, R., Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One, 3, 2008.
52. Xu, L., Shen, S.S., Hoshida, Y., Subramanian, A., Ross, K., Brunet, J.P., Wagner, S.N., Ramaswamy, S., Mesirov, J.P., Hynes, R.O., Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol. Cancer Res. 6 (2008), 760–769.
53. Zingg, D., Debbache, J., Schaefer, S.M., Tuncer, E., Frommel, S.C., Cheng, P., Arenas-Ramirez, N., Haeusel, J., Zhang, Y., Bonalli, M., et al. The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nat. Commun., 6, 2015.